5 reasons why quality management needs a GxP-regulated cloud
The global shift from traditional IT offerings to cloud services continues
Breaking News
PCI announces new facility dedicated to clinical trial returns
Continued investment at Bridgend site enables capacity expansion for segregated space in support of the return of ...
Recipharm releases first serialised products to Europe
Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised ...
To comply with EU FMD Fareva selects TraceLink
The API CDMO has selected the track and trace network provider, so that it can successfully connect with its ...
Preparing PIs for post EU-FMD success
Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel ...
PCI completes acquisition of Sherpa Clinical Packaging
The acquisition enhances PCI’s portfolio of molecule-to-market capabilities, adding sterile and non-sterile drug ...
First prescription CBD from GW Pharma has restriction lowered
The US Drug Enforcement Administration’s decision to move Epidiolex to Schedule V was based on non-clinical and ...
Serialisation and data connectivity: Part I
The new wrinkle in your supply chain
Patients could lose out on life-saving treatments
Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData
RFXCEL launches FMD compliance solution for pharmacy workflow
The new software has been adapted to build a workflow designed to enable dispensers to manage split packs, aggregation ...
The Falsified Medicines Directive: clarification for wholesalers, distributors and logistics partners
The Falsified Medicines Directive (FMD) 2011/62/EU comes into force on 9 February 2019
Discover, learn and connect at Lab Innovations!
Experience the latest developments at the UK’s only event dedicated to the laboratory industry
Why risk it? FMD is not going away! Are you ready?
The Falsified Medicines Directive (FMD) imposes strict serialisation requirements on pharmaceutical manufacturers, ...
Impact of trade agreements and regulatory divergence
CPhI Annual Report warns trade and patent changes could increase healthcare cost by $100bn in the next 5 years
Further development of CAR-T cell therapy requires industry input
Academic institutions globally are turning to immuno-oncology research to improve outcomes for young patients suffering ...
In Brief
Most Popular in Regulatory
- Preparing PIs for post EU-FMD success
- PCI announces new facility dedicated to clinical trial returns
- The Falsified Medicines Directive: clarification for wholesalers, distributors and logistics partners
- European Pharmacopoeia (Ph. Eur.) Commission adopts new monographs and makes a number of revisions
- SenzaGen recruits Business Development Director
Suppliers in regulatory
Reports
